Sun Pharmaceutical Industries Ltd Considers Internal Restructuring
Published: Aug 06, 2012
Drug major Sun Pharma today said its board will meet later this week to consider internal restructuring of the business and to announce first quarter results. The Mumbai-headquartered firm said in a filing to the BSE that its board on August 10 "would consider the internal restructuring of the business of the company with effect from March 31, 2012". The board will also announce the financial results of the company for the first quarter ended June 30, 2012. The board would also consider declaration of the interim dividend of Rs 4.25 per share of Re 1 each on equity shares of the company for the year ended March 31, 2012, the filing said.